Á lódáil...
Patient-reported outcome claims in European and United States orphan drug approvals
Purpose: We aimed to evaluate the rate of usage and the kind of patient-reported outcome (PRO) claims in orphan drug approvals from the European Medicines Agency (EMA) dated between 1/1/2012 and 31/12/2016 and to compare them to those from the US Food and Drug Administration (FDA). Methods: Orphan d...
Na minha lista:
| Foilsithe in: | J Mark Access Health Policy |
|---|---|
| Main Authors: | , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Routledge
2018
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6225506/ https://ncbi.nlm.nih.gov/pubmed/30425804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2018.1542920 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|